[Form 4] Caris Life Sciences, Inc. Insider Trading Activity
George Poste, a director of Caris Life Sciences (CAI), reported option exercise and share dispositions on 08/11/2025 resulting in changes to his beneficial ownership.
The filing shows a 125,000-share option exercise at $2.44, recorded as an acquisition. The report also lists two dispositions of common stock: 48,022 shares and 91,495 shares, each at $29.75. Table entries show sequential direct beneficial ownership figures of 359,754, 311,732 and 220,237 following the reported transactions, and an indirect holding of 307,594 shares through a family trust. The filing notes the underlying stock option is fully vested and exercisable, and the form was signed by an attorney-in-fact on behalf of the reporting person.
George Poste, amministratore di Caris Life Sciences (CAI), ha comunicato l'esercizio di opzioni e la cessione di azioni l'11/08/2025, con variazioni nella sua partecipazione beneficiaria.
La dichiarazione riporta l'esercizio di 125.000 opzioni a $2,44, registrato come acquisizione. Segnalate anche due cessioni di azioni ordinarie: 48.022 azioni e 91.495 azioni, entrambe a $29,75. Le voci tabellari indicano una titolarit脿 diretta sequenziale di 359.754, 311.732 e 220.237 dopo le operazioni riferite, e una detenzione indiretta di 307.594 azioni tramite un trust familiare. Il documento precisa che l'opzione sottostante 猫 completamente maturata e esercitabile e che il modulo 猫 stato firmato da un procuratore per conto della persona che effettua la comunicazione.
George Poste, director de Caris Life Sciences (CAI), declar贸 el ejercicio de opciones y la enajenaci贸n de acciones el 11/08/2025, con cambios en su participaci贸n beneficiaria.
El informe muestra el ejercicio de 125.000 opciones a $2,44, registrado como adquisici贸n. Tambi茅n figura la venta de dos bloques de acciones ordinarias: 48.022 acciones y 91.495 acciones, ambas a $29,75. Las entradas de la tabla reflejan una propiedad beneficiaria directa secuencial de 359.754, 311.732 y 220.237 tras las transacciones notificadas, y una tenencia indirecta de 307.594 acciones a trav茅s de un fideicomiso familiar. El formulario indica que la opci贸n subyacente est谩 totalmente consolidada y es ejercitable, y que el documento fue firmado por un apoderado en nombre del declarante.
Caris Life Sciences(CAI) 鞚挫偓鞚� George Poste臧� 2025-08-11鞐� 鞓奠厴 頄夓偓鞕赌 欤检嫕 觳橂秳鞚� 鞁犼碃頃橃棳 攴胳潣 鞁れ鞝� 氤挫湢 歆�攵勳澊 氤�瓴诫悩鞐堨姷雼堧嫟.
鞁犼碃靹涤棎电� $2.44鞐� 125,000欤� 鞓奠厴 頄夓偓臧� 旆摑鞙茧 旮半霅橃柎 鞛堨姷雼堧嫟. 霕愴暅 氤错喌欤� 2瓯挫潣 觳橂秳鞚� 旮办灛霅橃柎 鞛堨溂氅�, 48,022欤�鞕赌 91,495欤�臧� 臧侁皝 $29.75鞐� 觳橂秳霅橃棃鞀惦媹雼�. 響滌潣 頃鞚� 鞁犼碃霅� 瓯半灅 鞚错泟 歆侅爲 氤挫湢臧� 彀搿� 359,754欤�, 311,732欤�, 220,237欤�搿� 雮橅儉雮橂┌, 臧�臁� 鞁犿儊鞚� 韱淀暅 307,594欤�鞚� 臧勳爲 氤挫湢霃� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃靹滊姅 旮办磮 欤检嫕 鞓奠厴鞚� 鞕勳爠頌� 氩犾姢韺呺悩鞏� 頄夓偓 臧�電ロ暔鞚� 氇呾嫓頃橂┌, 頃措嫻 鞏戩嫕鞚� 氤搓碃鞚胳潉 雽�鞁犿暣 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
George Poste, administrateur de Caris Life Sciences (CAI), a d茅clar茅 l'exercice d'options et des cessions d'actions le 11/08/2025, entra卯nant des changements dans sa d茅tention effective.
Le d茅p么t indique l'exercice de 125 000 options 脿 $2,44, enregistr茅 comme acquisition. Le rapport mentionne 茅galement deux cessions d'actions ordinaires聽: 48 022 actions et 91 495 actions, chacune 脿 $29,75. Les lignes du tableau montrent successivement des d茅tentions directes de 359 754, 311 732 et 220 237 apr猫s les op茅rations d茅clar茅es, ainsi qu'une participation indirecte de 307 594 actions via une fiducie familiale. Le formulaire pr茅cise que l'option sous-jacente est pleinement acquise et exer莽able, et qu'il a 茅t茅 sign茅 par un mandataire au nom du d茅clarant.
George Poste, Direktor von Caris Life Sciences (CAI), meldete am 11.08.2025 die Aus眉bung von Optionen und Ver盲u脽erungen von Aktien, was 脛nderungen seines wirtschaftlichen Eigentums zur Folge hatte.
Die Meldung weist die Aus眉bung von 125.000 Optionen zu $2,44 aus, verbucht als Erwerb. Ebenfalls aufgef眉hrt sind zwei Ver盲u脽erungen von Stammaktien: 48.022 St眉ck und 91.495 St眉ck, jeweils zu $29,75. Die Tabellenangaben zeigen nacheinander direkte wirtschaftliche Eigentumswerte von 359.754, 311.732 und 220.237 nach den gemeldeten Transaktionen sowie eine indirekte Beteiligung von 307.594 Aktien 眉ber einen Familientrust. Die Einreichung stellt fest, dass die zugrunde liegende Aktienoption vollst盲ndig vested und aus眉bbar ist, und das Formular wurde von einem Bevollm盲chtigten im Namen der meldenden Person unterzeichnet.
- Clear disclosure of option exercise and share dispositions by a director, supporting regulatory transparency.
- Option fully vested and exercisable, indicating no vesting uncertainty for the reported grant.
- Substantial disposals totaling 139,517 shares (48,022 and 91,495) by a director, which reduced direct holdings shown in the filing.
- The filing shows a decline in direct beneficial ownership across the reported lines (from 359,754 to 220,237), which may be viewed unfavorably by some stakeholders.
Insights
TL;DR: Director exercised 125,000 options at $2.44 and sold 139,517 shares at $29.75, materially changing direct holdings reported.
The transaction set shows a large option exercise combined with two sizable dispositions. The exercise created 125,000 common shares at a low exercise price, while disposals totaling 139,517 shares were executed at $29.75 each. The reported line-item ownership figures decline across the entries from 359,754 to 220,237 direct shares, with an additional 307,594 shares held indirectly by a family trust. For investors, these disclosed movements alter the insider鈥檚 direct stake and should be tracked for subsequent ownership disclosures and potential signaling to the market. Impact assessment: not a corporate operational change but a material insider position shift.
TL;DR: Large insider option exercise and sales are fully disclosed; governance transparency maintained but direct ownership declined.
The Form 4 provides clear disclosure of the director鈥檚 activity: a fully vested option converted into 125,000 shares and two reported disposals at $29.75 per share. The filing also documents an indirect holding via a family trust. From a governance perspective, prompt, detailed reporting preserves compliance and transparency. The pattern鈥攅xercise plus immediate dispositions鈥攕hould be recorded in the company鈥檚 insider transaction history for stakeholder review, though the form itself contains no operational or financial guidance about company performance.
George Poste, amministratore di Caris Life Sciences (CAI), ha comunicato l'esercizio di opzioni e la cessione di azioni l'11/08/2025, con variazioni nella sua partecipazione beneficiaria.
La dichiarazione riporta l'esercizio di 125.000 opzioni a $2,44, registrato come acquisizione. Segnalate anche due cessioni di azioni ordinarie: 48.022 azioni e 91.495 azioni, entrambe a $29,75. Le voci tabellari indicano una titolarit脿 diretta sequenziale di 359.754, 311.732 e 220.237 dopo le operazioni riferite, e una detenzione indiretta di 307.594 azioni tramite un trust familiare. Il documento precisa che l'opzione sottostante 猫 completamente maturata e esercitabile e che il modulo 猫 stato firmato da un procuratore per conto della persona che effettua la comunicazione.
George Poste, director de Caris Life Sciences (CAI), declar贸 el ejercicio de opciones y la enajenaci贸n de acciones el 11/08/2025, con cambios en su participaci贸n beneficiaria.
El informe muestra el ejercicio de 125.000 opciones a $2,44, registrado como adquisici贸n. Tambi茅n figura la venta de dos bloques de acciones ordinarias: 48.022 acciones y 91.495 acciones, ambas a $29,75. Las entradas de la tabla reflejan una propiedad beneficiaria directa secuencial de 359.754, 311.732 y 220.237 tras las transacciones notificadas, y una tenencia indirecta de 307.594 acciones a trav茅s de un fideicomiso familiar. El formulario indica que la opci贸n subyacente est谩 totalmente consolidada y es ejercitable, y que el documento fue firmado por un apoderado en nombre del declarante.
Caris Life Sciences(CAI) 鞚挫偓鞚� George Poste臧� 2025-08-11鞐� 鞓奠厴 頄夓偓鞕赌 欤检嫕 觳橂秳鞚� 鞁犼碃頃橃棳 攴胳潣 鞁れ鞝� 氤挫湢 歆�攵勳澊 氤�瓴诫悩鞐堨姷雼堧嫟.
鞁犼碃靹涤棎电� $2.44鞐� 125,000欤� 鞓奠厴 頄夓偓臧� 旆摑鞙茧 旮半霅橃柎 鞛堨姷雼堧嫟. 霕愴暅 氤错喌欤� 2瓯挫潣 觳橂秳鞚� 旮办灛霅橃柎 鞛堨溂氅�, 48,022欤�鞕赌 91,495欤�臧� 臧侁皝 $29.75鞐� 觳橂秳霅橃棃鞀惦媹雼�. 響滌潣 頃鞚� 鞁犼碃霅� 瓯半灅 鞚错泟 歆侅爲 氤挫湢臧� 彀搿� 359,754欤�, 311,732欤�, 220,237欤�搿� 雮橅儉雮橂┌, 臧�臁� 鞁犿儊鞚� 韱淀暅 307,594欤�鞚� 臧勳爲 氤挫湢霃� 氤搓碃霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃靹滊姅 旮办磮 欤检嫕 鞓奠厴鞚� 鞕勳爠頌� 氩犾姢韺呺悩鞏� 頄夓偓 臧�電ロ暔鞚� 氇呾嫓頃橂┌, 頃措嫻 鞏戩嫕鞚� 氤搓碃鞚胳潉 雽�鞁犿暣 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
George Poste, administrateur de Caris Life Sciences (CAI), a d茅clar茅 l'exercice d'options et des cessions d'actions le 11/08/2025, entra卯nant des changements dans sa d茅tention effective.
Le d茅p么t indique l'exercice de 125 000 options 脿 $2,44, enregistr茅 comme acquisition. Le rapport mentionne 茅galement deux cessions d'actions ordinaires聽: 48 022 actions et 91 495 actions, chacune 脿 $29,75. Les lignes du tableau montrent successivement des d茅tentions directes de 359 754, 311 732 et 220 237 apr猫s les op茅rations d茅clar茅es, ainsi qu'une participation indirecte de 307 594 actions via une fiducie familiale. Le formulaire pr茅cise que l'option sous-jacente est pleinement acquise et exer莽able, et qu'il a 茅t茅 sign茅 par un mandataire au nom du d茅clarant.
George Poste, Direktor von Caris Life Sciences (CAI), meldete am 11.08.2025 die Aus眉bung von Optionen und Ver盲u脽erungen von Aktien, was 脛nderungen seines wirtschaftlichen Eigentums zur Folge hatte.
Die Meldung weist die Aus眉bung von 125.000 Optionen zu $2,44 aus, verbucht als Erwerb. Ebenfalls aufgef眉hrt sind zwei Ver盲u脽erungen von Stammaktien: 48.022 St眉ck und 91.495 St眉ck, jeweils zu $29,75. Die Tabellenangaben zeigen nacheinander direkte wirtschaftliche Eigentumswerte von 359.754, 311.732 und 220.237 nach den gemeldeten Transaktionen sowie eine indirekte Beteiligung von 307.594 Aktien 眉ber einen Familientrust. Die Einreichung stellt fest, dass die zugrunde liegende Aktienoption vollst盲ndig vested und aus眉bbar ist, und das Formular wurde von einem Bevollm盲chtigten im Namen der meldenden Person unterzeichnet.
FAQ
What transactions did George Poste report on the Form 4 for CAI?
How many shares does the Form 4 show as held indirectly by George Poste?
Is the exercised option exercisable and vested?
How did direct beneficial ownership figures change after the transactions?
